Eagle Pharma Securities Litigation Settlement
What happened
Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.
Do you qualify?
Anyone who purchased publicly traded common stock of Eagle Pharmaceuticals, Inc. between August 9, 2022 and October 1, 2024, inclusive.
How to file
Submit a Proof of Claim and Release form online or download a blank Claim Form from the Important Documents page and submit it by October 16, 2026. You must provide proof of your stock purchases during the class period to be eligible for payment.
Who's involved
Plaintiffs
- Joanna Pluta
- Liyu Wang
- NICHOLAS MILLER
Defendants
- BRIAN CAHILL
- SCOTT TARIFF
- EAGLE PHARMACEUTICALS, INC.
Counsel for plaintiffs
- JOSEPH COHENCOUNSEL NOT ADMITTED TO USDC - NJ BAR
- JACK ZWICKCOUNSEL NOT ADMITTED TO USDC-NJ BAR
- JAMES E. CECCHICARELLA BYRNE CECCHI BRODY & AGNELLO, P.C.
- KEVIN G. COOPERCARELLA BYRNE CECCHI BRODY & AGNELLO
Counsel for defendants
- MATTHEW JOSEPH CORRIELROPES & GRAY LLP
- KOJI F. FUKUMURACOUNSEL NOT ADMITTED TO USDC - NJ BAR
- BRIAN M. FRENCHCOUNSEL NOT ADMITTED TO USDC - NJ BAR
- ALEXANDER LEE CALLOSAUL EWING LLP
- SARAH ANN SULLIVANSAUL EWING LLP
Parties and counsel from the public court docket. Listing an attorney here isn't an endorsement, and ClaimWatch isn't affiliated with any of them.
In the news
Headlines via NewsAPI. ClaimWatch isn't affiliated with these publications.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Tattooed Chef Securities Settlement
Tattooed Chef, Inc. faced a securities lawsuit alleging that purchasers of the company's common stock were damaged. The defendant has agreed to settle all claims in the action for $4,750,000 in cash without admitting wrongdoing.
Estée Lauder Securities Settlement
Estée Lauder is settling securities litigation relating to alleged damages to investors who purchased or acquired publicly traded common stock of The Estée Lauder Companies Inc. during the class period. The defendant has not admitted wrongdoing in this settlement.
E-Commerce China Dangdang Securities Settlement
E-Commerce China Dangdang, Inc. was involved in a take-private transaction (merger) that closed on September 20, 2016. Shareholders who held American Depositary Shares during the Class Period claim they were harmed by undisclosed information related to the Company's take-private transaction. The defendant has agreed to settle these securities claims without admitting wrongdoing.
Evolv Technologies Holdings Securities Settlement
Investors purchased publicly traded common stock of Evolv Technologies Holdings Inc. during a specific period and are entitled to compensation from a securities class action settlement. The page does not explicitly state what wrongdoing Evolv allegedly committed.